Molecularly-Targeted and Biological Anti-Cancer Therapy

被引：1
|
作者：
Klener, P., Jr. [1 ,2 ,3 ,4 ]
Klener, P. [1 ,2 ,3 ,4 ]
机构：
[1] Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague 12853 2, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Ctr Expt Haematol, Prague 12853 2, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Dept Med 1, Dept Haematol, Prague 12853 2, Czech Republic
[4] Gen Univ Hosp, Prague, Czech Republic
来源：
FOLIA BIOLOGICA | 2012年 / 58卷 / 01期
关键词：
targeted therapy; biological therapy; biopharmaceutical; biosimilar; tailored therapy; personalized medicine; ANTIBODIES; CD20;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1 / 6
页数：6
相关论文
共 50 条
  • [41] Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy
    A Savonarola
    R Palmirotta
    F Guadagni
    F Silvestris
    [J]. The Pharmacogenomics Journal, 2012, 12 : 277 - 286
  • [42] Pyrazolopyridine-based kinase inhibitors for anti-cancer targeted therapy
    Halder, Pallabi
    Rai, Anubhav
    Talukdar, Vishal
    Das, Parthasarathi
    Lakkaniga, Naga Rajiv
    [J]. RSC MEDICINAL CHEMISTRY, 2024, 15 (05): : 1452 - 1470
  • [43] Targeted Anti-Cancer Therapies for Renal Cancer
    Robert J. Amato
    Jaroslaw Jac
    [J]. Drugs, 2006, 66 : 2161 - 2171
  • [44] Mitochondrially targeted anti-cancer agents
    Biasutto, Lucia
    Dong, Lan-Feng
    Zoratti, Mario
    Neuzil, Jiri
    [J]. MITOCHONDRION, 2010, 10 (06) : 670 - 681
  • [45] A comprehensive analysis of proteins involved in innate and acquired resistance to molecularly-targeted drugs in breast cancer cells
    Montazeri, Hamid
    [J]. CANCER RESEARCH, 2016, 76
  • [46] Antibody-Drug Conjugates: A Review on the Epitome of Targeted Anti-Cancer Therapy
    Hasan, Mahmudul
    Alam, Safaet
    Poddar, Saikat Kumar
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (04): : 236 - 251
  • [47] Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
    Crisci, Stefania
    Amitrano, Filomena
    Saggese, Mariangela
    Muto, Tommaso
    Sarno, Sabrina
    Mele, Sara
    Vitale, Pasquale
    Ronga, Giuseppina
    Berretta, Massimiliano
    Di Francia, Raffaele
    [J]. MEDICINA-LITHUANIA, 2019, 55 (08):
  • [48] Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy
    Yan, Ruiyang
    Hallam, Andrew
    Stockley, Peter G.
    Boyes, Joan
    [J]. BIOCHEMICAL JOURNAL, 2014, 461 : 1 - 13
  • [49] Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
    Mohanty, Ayeskanta
    Uthaman, Saji
    Park, In-Kyu
    [J]. MOLECULES, 2020, 25 (19):
  • [50] Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy
    Asor, Eyal
    Stav, Michael Y.
    Simon, Einav
    Fahoum, Ibrahim
    Sabo, Edmond
    Ben-Izhak, Ofer
    Hershkovitz, Dov
    [J]. PLOS ONE, 2017, 12 (03):
12345